30 completed, 2 withdrawn, 1 terminated. 33 Phase 2, 4 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 33 | Completed 30, Withdrawn 2, Terminated 1 |
| Phase 3 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 3 | Completed 3 |
Follow Saquinavir: new trials by email Literature Review of Saquinavir trials Research Report on Saquinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children. ritonavir, saquinavir [Invirase] - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 18 | 2008-06-01 | 2016-03-07 |
| Pharmacokinetics of Low Dose Ritonavir ritonavir and saquinavir - HIV Infections | Phase 1 / Phase 2 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 20 | 2008-01-01 | 2012-04-05 |
| Clinical Trial of CNS-targeted HAART (CIT2) FDA Approved Antiretroviral Therapy (see list below) - HIV Infections | Phase 2 / Phase 3 | Completed | University of California, San Diego | 59 | 2007-03-01 | 2014-04-23 |
| Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) Fosamprenavir, Saquinavir - HIV Infections | Phase 2 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 61 | 2005-12-01 | 2026-04-02 |
| The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. Saquinavir and Ritonavir - HIV Infections | Phase 1 / Phase 2 | Completed | Radboud University Medical Center | 40 | 2005-08-01 | 2020-10-19 |
| Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity Saquinavir - IDV Associated Nephrotoxicity | Phase 2 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 30 | 2004-05-01 | 2016-02-22 |
| The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients Saquinavir, lopinavir, ritonavir - HIV Infections | Phase 2 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 48 | 2004-03-01 | 2012-04-05 |
| Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients tipranavir, ritonavir, saquinavir - HIV Infections | Phase 2 | Completed | Boehringer Ingelheim | 328 | 2003-02-18 | 2023-12-01 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 266 | 2002-08-01 | 2021-11-05 |
| Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects Lopinavir/ritonavir, Saquinavir mesylate, Lamivudine/zidovudine - HIV Infections | Phase 2 | Completed | Abbott | 30 | 2002-08-01 | 2007-09-27 |
| Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor Amprenavir/ritonavir, Saquinavir/ritonavir - HIV Infections | Phase 2 / Phase 3 | Completed | Abbott | 16 | 2001-04-01 | 2006-07-28 |
| Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART Amprenavir/ritonavir, Saquinavir/ritonavir, Efavirenz - HIV Infections | Phase 2 | Completed | Abbott | 24 | 2001-04-01 | 2008-04-01 |
| Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients Tipranavir (TPV) low dose, Tipranavir (TPV) high dose, Ritonavir low dose - HIV Infections | Phase 2 | Terminated | Boehringer Ingelheim | 79 | 1999-12-01 | 2014-09-15 |
| Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment Atazanavir, Ritonavir, Saquinavir - HIV Infections | Phase 2 | Completed | Bristol-Myers Squibb | 1999-12-01 | 2011-05-04 | |
| Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma indinavir sulfate, nelfinavir mesylate, paclitaxel - Sarcoma | Phase 2 | Completed | Eastern Cooperative Oncology Group | 33 | 1997-12-15 | 2023-06-15 |
| Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance Lopinavir/ritonavir, Ritonavir, Saquinavir - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 118 | 2011-03-01 | |
| Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV Lopinavir/ritonavir, Saquinavir - HIV Infections | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 26 | 2021-11-01 | |
| The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs Ritonavir, Nelfinavir mesylate, Efavirenz - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-11-01 | |
| A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs Saquinavir, Lamivudine, Stavudine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 140 | 2005-06-24 | |
| A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine Saquinavir, Zalcitabine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 900 | 2005-06-24 |
Showing 20 of 33. Sign in to see all of them.
HIV Infections (30) · Acquired Immunodeficiency Syndrome (6) · AIDS-Related Complex (5) · AIDS Dementia Complex (1) · AIDS-related Kaposi sarcoma (1) · Cognitive Dysfunction (1) · Hypersensitivity, Delayed (1) · Sarcoma (1) · Sarcoma, Kaposi (1) · Viremia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (11) · Hoffmann-La Roche (5) · The HIV Netherlands Australia Thailand Research Collaboration (4) · Abbott (3) · Boehringer Ingelheim (2) · Bristol-Myers Squibb (1) · Eastern Cooperative Oncology Group (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Gilead Sciences (1) · Glaxo Wellcome (1) · Parexel (1) · Radboud University Medical Center (1) · University of California, San Diego (1)
United States (25) · Puerto Rico (11) · Canada (7) · France (5) · Thailand (5) · Germany (4) · Italy (4) · Spain (4) · United Kingdom (4) · Argentina (3) · Brazil (2) · Netherlands (2) · Poland (2) · Australia (1) · Belgium (1)
Kiat Ruxrungtham, MD (3) · Scott Hammer (3) · Eugene Sun, M.D. (2) · Andrew Wiznia, MD (1) · Ann J. Melvin, MD (1) · Ann J. Melvin, MD, MPH (1) · Barbara A da Silva, M.D. (1) · Bartlett J (1) · Collier A (1) · Collier AC (1) · Coombs R (1) · Corey L (1) · Courtney Fletcher (1)
PMID 17726714, PMID 18625762, PMID 18647794, PMID 19118378, PMID 19420019, PMID 19474478, PMID 21288774, PMID 21337357, PMID 24352352, PMID 27516476
2005 (1), R01MH058076 (1)